期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

组蛋白去乙酰化酶抑制剂在甲状腺癌治疗中的进展 被引量：2

下载PDF
导出
作者 于丽菠 袁耿彪
机构地区 重庆医科大学附属第二医院核医学科
出处 《重庆医学》 CAS CSCD 北大核心 2010年第8期988-990,共3页 Chongqing medicine
基金 重庆市科委自然基金资助项目(2007BB5310)
关键词 甲状腺癌 组蛋白 组蛋白去乙酰化酶 放射性碘
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Jemal A,Siegel R,Ward E,et al.Canaer statistics,2007[J].CA Cancer J Clin,2007,57(1):43.
  • 2Cooper DS,Doherty GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer:the American thyroid association guidelines taskforee[J].Thyroid,2006,16(2):109.
  • 3Jung M,Kozikowski A,Dritsehilo A.Rational design and development of radiation sensitizing histone deacetylase inhibitors[J].Chem Biodivers,2005,2(11):1452.
  • 4Backs J,Song K,Bezprozvannaya S,et al.CaM kinase Ⅱ selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy[J].J Clin Invest,2006,116(7):1853.
  • 5Kim S,Kang JK,Kim YK,et al.Histone deacetylase inhibitor apicidin induces eyclin E expression through Spl sites[J].Biochem Biophys Res Commun,2006,342(4):1168.
  • 6Rokhlin OW,Glover RB,Guseva NV,et al.Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor positive prostate cancer cells[J].Mol Cancer Res,2006,4(2):113.
  • 7Verdone L,Agricola E,Caserta M,et al.Histone acetylation in gene regulation[J].Brief Funct Genomic Proteomic.2006,5(3):209.
  • 8Monneret C.Histone deacetylase inhibitors[J].Eur J Med Chem,2005,40(1):1.
  • 9Bolden JE,Peart MJ,Johnstone RW,et al.Anticancer activities of histone deacetylase inhibitors[J].Nat Rev Drug Discov,2006,5(9):769.
  • 10Bhalla KN.Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies[J].Clin Oncol,2005,23(17):3971.

二级参考文献3

共引文献2

同被引文献25

  • 1黄菊,程夏楷,杨彬,吴兴中.E-钙黏蛋白复合体及其对肿瘤细胞的作用[J].生命的化学,2005,25(3):247-250. 被引量：19
  • 2Nix P,Nicolaides A,Coatesworth AP.Thyroid cancer review:Presentation and investigation of thyroid cancer[J].Int J Clin Pract,2005,59(11):1340-1344.
  • 3Jones PA,Martienssen R.A blueprint for a human epigenome project the AACR human epigenome workshop[J].Cancer Res,2005,65(24):11241-11246.
  • 4Hoque MO,Rosenbaum E,Westra WH,et al.Quantitative assessment of promoter methylation profiles in thyroid neoplasm[J].Clin Endocrinol Metab,2005,90(7):4011-4018.
  • 5Jing F,Zhang J,Tao J,et al.Hypermethylation of tumor suppressor genes BRCA1,p16 and 14-3-3 sigma in serum of sporadic breast cancer patients[J].Onkologie,2007,30(1/2):14-19.
  • 6Das PM,Single R.DNA methylation and cancer[J].J Clin Oncol,2004,22(9):4632-4642.
  • 7Costello JF,Plass C.Methylation matters[J].J Med Genet,2001,38(5):285-303.
  • 8Takaguchi M,Achanzar WE,Qu W,et al.Effects of cadmium on DNA-(Cytosine-25)methyl transferase activity and DNA methylation status during cadmium-induced cellular transformation[J].Cell Res,2003,286(2):355-365.
  • 9Szyf M.Targeting DNA methylation in cancer[J].Ageing Res Rev,2003,2(3):299-328.
  • 10Feng H,Cheung AN,Xue WC,et al.Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma[J].Gynecol Oncol,2004,94(2):375-382.

引证文献2

二级引证文献13

重庆医学
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部